Matt Sherwood
Matt Sherwood is a final-year PhD student from the University of Southampton working at The Pirbright Institute. Employing a combination of wet-lab and computational omic-based approaches, Matt is researching how the Zika virus can be used as a potential new therapy to treat aggressive childhood nervous system tumours.
Degrees:
- PhD Student, University of Southampton & The Pirbright Institute, 2020-2024
- MRes Stem Cells, Development & Regenerative Medicine (Distinction), University of Southampton, 2017-2018
- BSc Biochemistry (First Class Honours), University of Bristol, 2013-201
Conferences
- Hepacivirus and Flavivirus Meeting (Talk, UK, 2024)
- International Society of Paediatric Oncology (Poster, Spain, 2022)
- Society for Neuro-Oncology Annual Meeting (Poster, USA, 2022)
- Cancer Research UK Brain Tumour Conference (Poster, UK, 2022)
- Children's Cancer and Leukaemia Group Winter Meeting (Poster, UK, 2022)
- Society for Neuro-Oncology Basic and Translational Science Conference (Poster, Virtual, 2021)
Awards
- Doctoral College Directors Award, The University of Southampton, 2023